Abstract
The prevalence of non-cardiac chest pain in general population has been estimated as 13%. Non-cardiac chest pain might be caused by either acid reflux, esophageal motility disorders, eosinophilic esophagitis or visceral hypersensitivity (functional chest pain). After a cardiac cause of chest pain has been excluded, a short-term trial with proton pomp inhibitor (PPI) is the most cost-effective method for assessing whether non-cardiac chest pain is due to acid reflux. Upper endoscopy with biopsies of the esophagus are recommended to exclude erosive or eosinophilic esophagitis as possible causes of chest pain. In patients with persistent chest pain despite short-term PPIs trial the next step is to perform 24-h distal esophageal pH monitoring or 48-h wireless distal esophageal pH monitoring off PPI therapy to provide objective evidence whether acid reflux is present. After excluding acid reflux, the next step is to perform esophageal manometry to determine whether a major esophageal motility abnormality may be causing the chest pain such as achalasia, esophagogastric junction outflow obstruction, jackhammer esophagus, diffuse esophageal spasm, or absent peristalsis. After exclusion of acid reflux, eosinophilic esophagitis, or esophageal motility abnormality, the diagnosis of non-cardiac chest pain due to visceral hypersensitivity (functional chest pain) can be made. Treatment options of functional chest pain include theophylline, low-dose antidepressants (imipramine, trazodone, sertraline, or venlafaxine), or psychological interventions such as cognitive behavioral therapy or hypnotherapy.
This chapter discusses the epidemiology, pathophysiology, diagnosis, and management of non-cardiac chest pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ford AC, Suares NC, Talley NJ. Meta-analysis: the epidemiology of noncardiac chest pain in the community. Aliment Pharmacol Ther. 2011;34:172–80.
Cervero F, Laird JM. Visceral pain. Lancet. 1999;353:2145–8.
Sengupta JN. An overview of esophageal sensory receptors. Am J Med. 2000;108(Suppl 4a):87S–9S.
Rodrigo J, Hernandez J, Vidal MA, et al. Vegetative innervation of the esophagus. II. Intraganglionic laminar endings. Acta Anat (Basel). 1975;92:79–100.
Rodrigo J, Hernandez CJ, Vidal MA, et al. Vegetative innervation of the esophagus. III. Intraepithelial endings. Acta Anat (Basel). 1975;92:242–58.
Pedrosa JA, Hernandez CJ, Rodrigo J, et al. Vegetative innervation of the esophagus. IV. Endings in the tela submucosa and tunica muscularis. Acta Anat (Basel). 1976;95:452–67.
Khurana RK, Petras JM. Sensory innervation of the canine esophagus, stomach, and duodenum. Am J Anat. 1991;192:293–306.
Altschuler SM, Bao XM, Bieger D, et al. Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary and spinal trigeminal tracts. J Comp Neurol. 1989;283:248–68.
Zagorodnyuk VP, Brookes SJ. Transduction sites of vagal mechanoreceptors in the guinea pig esophagus. J Neurosci. 2000;20:6249–55.
Zagorodnyuk VP, Chen BN, Costa M, et al. Mechanotransduction by intraganglionic laminar endings of vagal tension receptors in the guinea-pig oesophagus. J Physiol. 2003;553:575–87.
Geppetti P, Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br J Pharmacol. 2004;141:1313–20.
Waldmann R, Champigny G, Bassilana F, et al. A proton-gated cation channel involved in acid-sensing. Nature. 1997;386:173–7.
Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816–24.
Holzer P. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur J Pharmacol. 2004;500:231–41.
Bassilana F, Champigny G, Waldmann R, et al. The acid-sensitive ionic channel subunit ASIC and the mammalian degenerin MDEG form a heteromultimeric H+−gated Na+ channel with novel properties. J Biol Chem. 1997;272:28819–22.
Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 1987;26(8):1235.
Haley JE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 1990;518:218–26.
Zhang S, Liu Z, Heldsinger A, et al. Intraluminal acid activates esophageal nodose C fibers after mast cell activation. Am J Physiol Gastrointest Liver Physiol. 2014;306:G200–7.
Garrison DW, Chandler MJ, Foreman RD. Viscerosomatic convergence onto feline spinal neurons from esophagus, heart and somatic fields: effects of inflammation. Pain. 1992;49:373–82.
Willert RP, Woolf CJ, Hobson AR, et al. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Gastroenterology. 2004;126:683–92.
Newton M, Kamm MA, Soediono PO, et al. Oesophageal epithelial innervation in health and reflux oesophagitis. Gut. 1999;44:317–22.
Matthews PJ, Aziz Q, Facer P, et al. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol. 2004;16:897–902.
Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology. 1958;34:760–81.
Smith JL, Opekun AR, Larkai E, et al. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology. 1989;96:683–9.
Hewson EG, Sinclair JW, Dalton CB, et al. Acid perfusion test: does it have a role in the assessment of non cardiac chest pain? Gut. 1989;30:305–10.
Mehta AJ, De Caestecker JS, Camm AJ, et al. Sensitization to painful distention and abnormal sensory perception in the esophagus. Gastroenterology. 1995;108:311–9.
WH H, Martin CJ, Talley NJ. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study. Am J Gastroenterol. 2000;95:2189–94.
Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology. 1998;115:1363–73.
Sarkar S, Thompson DG, Woolf CJ, et al. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am J Gastroenterol. 2004;99:1998–2006.
DeMeester TR, O'Sullivan GC, Bermudez G, et al. Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg. 1982;196:488–98.
Singh S, Richter JE, Hewson EG, et al. The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann Intern Med. 1992;117:824–30.
Dickman R, Mattek N, Holub J, et al. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol. 2007;102:1173–9.
Jerlock M, Welin C, Rosengren A, et al. Pain characteristics in patients with unexplained chest pain and patients with ischemic heart disease. Eur J Cardiovasc Nurs. 2007;6:130–6.
Steele R, McNaughton T, McConahy M, et al. Chest pain in emergency department patients: if the pain is relieved by nitroglycerin, is it more likely to be cardiac chest pain? CJEM. 2006;8:164–9.
Mousavi S, Tosi J, Eskandarian R, et al. Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain. J Gastroenterol Hepatol. 2007;22:218–21.
Kim JH, Rhee PL, Park EH, et al. Clinical usefulness of subgrouping of patients with non-cardiac chest pain according to characteristic symptoms in Korea. J Gastroenterol Hepatol. 2007;22:320–5.
Ofman JJ, Gralnek IM, Udani J, et al. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med. 1999;107:219–27.
Cremonini F, Wise J, Moayyedi P, et al. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol. 2005;100:1226–32.
Kahrilas PJ, Hughes N, Howden CW. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Gut. 2011;60:1473–8.
Fass R, Malagon I, Schmulson M. Chest pain of esophageal origin. Curr Opin Gastroenterol. 2001;17:376–80.
Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005;100:283–9.
Richter JE, Pandolfino JE, Vela MF, et al. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group. Dis Esophagus. 2013;26:755–65.
Hershcovici T, Achem SR, Jha LK, et al. Systematic review: the treatment of noncardiac chest pain. Aliment Pharmacol Ther. 2012;35:5–14.
Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998;115:42–9.
Laine L, Nagar A. Long-term PPI use: balancing potential harms and documented benefits. Am J Gastroenterol. 2016;111:913–5.
George N, Abdallah J, Maradey-Romero C, et al. Review article: the current treatment of non-cardiac chest pain. Aliment Pharmacol Ther. 2016;43:213–39.
Liu JJ, Carr-Locke DL, Osterman MT, et al. Endoscopic treatment for atypical manifestations of gastroesophageal reflux disease. Am J Gastroenterol. 2006;101:440–5.
Jobe BA, Richter JE, Hoppo T, et al. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the esophageal diagnostic advisory panel. J Am Coll Surg. 2013;217:586–97.
Stefanidis D, Hope WW, Kohn GP, et al. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24:2647–69.
Mudipalli RS, Remes-Troche JM, Andersen L, et al. Functional chest pain: esophageal or overlapping functional disorder. J Clin Gastroenterol. 2007;41:264–9.
Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders. Gastroenterology. 2016;150:1368–79.
Hobson AR, Furlong PL, Sarkar S, et al. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology. 2006;130:80–8.
Hollerbach S, Bulat R, May A, et al. Abnormal cerebral processing of oesophageal stimuli in patients with noncardiac chest pain (NCCP). Neurogastroenterol Motil. 2000;12:555–65.
Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology. 1986;91:845–52.
Rao SS, Gregersen H, Hayek B, et al. Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med. 1996;124:950–8.
Rao SS, Hayek B, Summers RW. Functional chest pain of esophageal origin: hyperalgesia or motor dysfunction. Am J Gastroenterol. 2001;96(9):2584.
Sarkar S, Aziz Q, Woolf CJ, et al. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet. 2000;356:1154–9.
Sarkar S, Hobson AR, Furlong PL, et al. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1196–202.
Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology. 2006;130:1459–65.
Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2011;9:868–74.
Nasr I, Attaluri A, Coss-Adame E, et al. Diagnostic utility of the oesophageal balloon distension test in the evaluation of oesophageal chest pain. Aliment Pharmacol Ther. 2012;35:1474–81.
Coss-Adame E, Erdogan A, Rao SS. Treatment of esophageal (noncardiac) chest pain: an expert review. Clin Gastroenterol Hepatol. 2014;12:1224–45.
de Bortoli N, Martinucci I, Savarino E, et al. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil. 2014;26:28–35.
Dickman R, Maradey-Romero C, Fass R. The role of pain modulators in esophageal disorders - no pain no gain. Neurogastroenterol Motil. 2014;26:603–10.
Nguyen TM, Eslick GD. Systematic review: the treatment of noncardiac chest pain with antidepressants. Aliment Pharmacol Ther. 2012;35:493–500.
Atluri DK, Chandar AK, Fass R, et al. Systematic review with meta-analysis: selective serotonin reuptake inhibitors for noncardiac chest pain. Aliment Pharmacol Ther. 2015;41:167–76.
Bueno L, Fioramonti J, Delvaux M, et al. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology. 1997;112:1714–43.
Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol. 1998;347:1–11.
Pappagallo M, Gaspardone A, Tomai F, et al. Analgesic effect of bamiphylline on pain induced by intradermal injection of adenosine. Pain. 1993;53:199–204.
Sylven C, Beermann B, Jonzon B, et al. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J (Clin Res Ed). 1986;293:227–30.
Sylven C, Jonzon B, Edlund A. Angina pectoris-like pain provoked by i.V. Bolus of adenosine: relationship to coronary sinus blood flow, heart rate and blood pressure in healthy volunteers. Eur Heart J. 1989;10:48–54.
Crea F, Pupita G, Galassi AR, et al. Role of adenosine in pathogenesis of anginal pain. Circulation. 1990;81:164–72.
Rao SS, Mudipalli RS, Remes-Troche JM, et al. Theophylline improves esophageal chest pain--a randomized, placebo-controlled study. Am J Gastroenterol. 2007;102:930–8.
Kisely SR, Campbell LA, Yelland MJ, et al. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev. 2015:CD004101.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Blonski, W., Richter, J.E. (2018). Chest Pain of Esophageal Origin and Reflux Hypersensitivity. In: Bardan, E., Shaker, R. (eds) Gastrointestinal Motility Disorders . Springer, Cham. https://doi.org/10.1007/978-3-319-59352-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-59352-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59350-0
Online ISBN: 978-3-319-59352-4
eBook Packages: MedicineMedicine (R0)